Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR-060604)
National Institutes of Health (UL1TR001412, R01-NS-064592, R01-NS-091075)
Text and Data Mining valid from 2019-11-09
Received: 8 July 2019
Accepted: 23 September 2019
First Online: 9 November 2019
Ethics approval and consent to participate
: This project was reviewed and approved by the IRBs of the University of Oklahoma Health Sciences Center, the University at Buffalo, and Seattle Children’s Hospital. All research was conducted according to the IRB-approved protocol, and informed consent was obtained from all subjects.
: No specific patient information/images are presented in the manuscript. Consent documents for this study explicitly state that data will be published but that individual subjects will remain anonymous.
: KEP, KJ, LL, YS, CAW, TH, and JNJ declare that they have no competing interests. HM is a principal investigator: three Brain Aneurysm Foundation grants (no applicable grant numbers), NIH Grants R01-NS-091075 and R01-NS-064592, and Grant support Canon Medical Systems. HM is a co-founder of Neurovascular Diagnostics, Inc.